Ionis Pharmaceuticals, Inc. (IONS)
26.60
-0.62
(-2.28%)
USD |
NASDAQ |
Nov 20, 16:00
26.60
0.00 (0.00%)
After-Hours: 19:15
Ionis Pharmaceuticals Gross Profit (TTM) : 915.88M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 915.88M |
| June 30, 2026 | 835.84M |
| March 31, 2026 | 1.023B |
| December 31, 2025 | 912.39M |
| September 30, 2025 | 939.02M |
| June 30, 2025 | 914.77M |
| March 31, 2025 | 685.24M |
| December 31, 2024 | 672.18M |
| September 30, 2024 | 770.84M |
| June 30, 2024 | 780.02M |
| March 31, 2024 | 744.69M |
| December 31, 2023 | 756.57M |
| September 30, 2023 | 581.16M |
| June 30, 2023 | 597.89M |
| March 31, 2023 | 541.66M |
| December 31, 2022 | 550.94M |
| September 30, 2022 | 842.99M |
| June 30, 2022 | 815.14M |
| March 31, 2022 | 808.96M |
| December 31, 2021 | 780.28M |
| September 30, 2021 | 629.69M |
| June 30, 2021 | 656.93M |
| March 31, 2021 | 677.64M |
| December 31, 2020 | 700.18M |
| September 30, 2020 | 906.34M |
| Date | Value |
|---|---|
| June 30, 2020 | 917.04M |
| March 31, 2020 | 937.34M |
| December 31, 2019 | 1.103B |
| September 30, 2019 | 802.48M |
| June 30, 2019 | 639.24M |
| March 31, 2019 | 480.44M |
| December 31, 2018 | 187.81M |
| September 30, 2018 | 171.30M |
| June 30, 2018 | 171.30M |
| March 31, 2018 | 171.30M |
| December 31, 2017 | 171.30M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.874B |
| Arrowhead Pharmaceuticals, Inc. | 422.57M |
| BridgeBio Pharma, Inc. | 890.06M |
| Biogen, Inc. | 6.335B |
| TG Therapeutics, Inc. | 742.84M |